nodes	percent_of_prediction	percent_of_DWPC	metapath
Propylthiouracil—MPO—Carboplatin—ovarian cancer	0.475	1	CbGbCtD
Propylthiouracil—TPO—Thyroxine (Thyroid Hormone) Production—TG—ovarian cancer	0.0659	0.253	CbGpPWpGaD
Propylthiouracil—DIO1—Thyroxine biosynthesis—SLC5A5—ovarian cancer	0.0276	0.106	CbGpPWpGaD
Propylthiouracil—DIO1—Selenium Metabolism and Selenoproteins—SELENBP1—ovarian cancer	0.0206	0.079	CbGpPWpGaD
Propylthiouracil—TPO—Thyroxine (Thyroid Hormone) Production—SLC5A5—ovarian cancer	0.02	0.0768	CbGpPWpGaD
Propylthiouracil—DIO1—Amine-derived hormones—SLC5A5—ovarian cancer	0.0159	0.061	CbGpPWpGaD
Propylthiouracil—TPO—Thyroxine biosynthesis—SLC5A5—ovarian cancer	0.0159	0.061	CbGpPWpGaD
Propylthiouracil—Drug fever—Chlorambucil—ovarian cancer	0.00994	0.0395	CcSEcCtD
Propylthiouracil—DBH—Amine-derived hormones—SLC5A5—ovarian cancer	0.00969	0.0372	CbGpPWpGaD
Propylthiouracil—DBH—Monoamine Transport—RBL2—ovarian cancer	0.0095	0.0365	CbGpPWpGaD
Propylthiouracil—TPO—Amine-derived hormones—SLC5A5—ovarian cancer	0.00911	0.035	CbGpPWpGaD
Propylthiouracil—DBH—Monoamine Transport—PVRL2—ovarian cancer	0.00864	0.0332	CbGpPWpGaD
Propylthiouracil—MPO—Folate Metabolism—FOLR1—ovarian cancer	0.00744	0.0286	CbGpPWpGaD
Propylthiouracil—Interstitial pneumonia—Chlorambucil—ovarian cancer	0.00687	0.0273	CcSEcCtD
Propylthiouracil—Interstitial pneumonia—Melphalan—ovarian cancer	0.00599	0.0238	CcSEcCtD
Propylthiouracil—Neuropathy peripheral—Altretamine—ovarian cancer	0.00512	0.0204	CcSEcCtD
Propylthiouracil—Pigmentation disorder—Paclitaxel—ovarian cancer	0.00509	0.0203	CcSEcCtD
Propylthiouracil—Interstitial lung disease—Chlorambucil—ovarian cancer	0.00469	0.0187	CcSEcCtD
Propylthiouracil—DIO1—testis—ovarian cancer	0.00446	0.324	CbGeAlD
Propylthiouracil—Neuritis—Chlorambucil—ovarian cancer	0.00445	0.0177	CcSEcCtD
Propylthiouracil—Drug fever—Docetaxel—ovarian cancer	0.00432	0.0172	CcSEcCtD
Propylthiouracil—Interstitial lung disease—Topotecan—ovarian cancer	0.00417	0.0166	CcSEcCtD
Propylthiouracil—Interstitial lung disease—Melphalan—ovarian cancer	0.00409	0.0163	CcSEcCtD
Propylthiouracil—Skin ulcer—Melphalan—ovarian cancer	0.00372	0.0148	CcSEcCtD
Propylthiouracil—Vertigo—Altretamine—ovarian cancer	0.00367	0.0146	CcSEcCtD
Propylthiouracil—Leukopenia—Altretamine—ovarian cancer	0.00365	0.0145	CcSEcCtD
Propylthiouracil—Interstitial pneumonia—Paclitaxel—ovarian cancer	0.00352	0.014	CcSEcCtD
Propylthiouracil—DIO1—Selenium Micronutrient Network—SOD1—ovarian cancer	0.00335	0.0129	CbGpPWpGaD
Propylthiouracil—Thrombocytopenia—Altretamine—ovarian cancer	0.00326	0.013	CcSEcCtD
Propylthiouracil—DIO1—Selenium Micronutrient Network—SOD2—ovarian cancer	0.00301	0.0116	CbGpPWpGaD
Propylthiouracil—Interstitial pneumonia—Docetaxel—ovarian cancer	0.00298	0.0119	CcSEcCtD
Propylthiouracil—Vasculitis—Melphalan—ovarian cancer	0.00296	0.0118	CcSEcCtD
Propylthiouracil—Pigmentation disorder—Epirubicin—ovarian cancer	0.00291	0.0116	CcSEcCtD
Propylthiouracil—Lymphadenopathy—Chlorambucil—ovarian cancer	0.00282	0.0112	CcSEcCtD
Propylthiouracil—Pigmentation disorder—Doxorubicin—ovarian cancer	0.00269	0.0107	CcSEcCtD
Propylthiouracil—Renal failure acute—Chlorambucil—ovarian cancer	0.00261	0.0104	CcSEcCtD
Propylthiouracil—Interstitial lung disease—Paclitaxel—ovarian cancer	0.0024	0.00955	CcSEcCtD
Propylthiouracil—Aplastic anaemia—Vinorelbine—ovarian cancer	0.00237	0.00944	CcSEcCtD
Propylthiouracil—Neuritis—Paclitaxel—ovarian cancer	0.00228	0.00906	CcSEcCtD
Propylthiouracil—Renal failure acute—Melphalan—ovarian cancer	0.00227	0.00905	CcSEcCtD
Propylthiouracil—Erythema nodosum—Epirubicin—ovarian cancer	0.00225	0.00894	CcSEcCtD
Propylthiouracil—DIO1—Amino acid and derivative metabolism—SLC5A5—ovarian cancer	0.00221	0.00849	CbGpPWpGaD
Propylthiouracil—Skin ulcer—Paclitaxel—ovarian cancer	0.00218	0.00869	CcSEcCtD
Propylthiouracil—Vomiting—Altretamine—ovarian cancer	0.00212	0.00843	CcSEcCtD
Propylthiouracil—Erythema nodosum—Doxorubicin—ovarian cancer	0.00208	0.00827	CcSEcCtD
Propylthiouracil—Hepatic failure—Vinorelbine—ovarian cancer	0.00204	0.00812	CcSEcCtD
Propylthiouracil—Interstitial lung disease—Docetaxel—ovarian cancer	0.00204	0.0081	CcSEcCtD
Propylthiouracil—TPO—testis—ovarian cancer	0.00201	0.146	CbGeAlD
Propylthiouracil—Nausea—Altretamine—ovarian cancer	0.00198	0.00787	CcSEcCtD
Propylthiouracil—Neuritis—Docetaxel—ovarian cancer	0.00193	0.00768	CcSEcCtD
Propylthiouracil—MPO—Vitamin B12 Metabolism—SOD1—ovarian cancer	0.00186	0.00717	CbGpPWpGaD
Propylthiouracil—Neuropathy peripheral—Chlorambucil—ovarian cancer	0.00182	0.00724	CcSEcCtD
Propylthiouracil—Body temperature increased—Carboplatin—ovarian cancer	0.00182	0.00724	CcSEcCtD
Propylthiouracil—Jaundice—Chlorambucil—ovarian cancer	0.00181	0.0072	CcSEcCtD
Propylthiouracil—Ageusia—Docetaxel—ovarian cancer	0.00178	0.00707	CcSEcCtD
Propylthiouracil—MPO—Vitamin B12 Metabolism—SOD2—ovarian cancer	0.00168	0.00645	CbGpPWpGaD
Propylthiouracil—DBH—female reproductive system—ovarian cancer	0.00162	0.118	CbGeAlD
Propylthiouracil—Neuropathy peripheral—Topotecan—ovarian cancer	0.00162	0.00644	CcSEcCtD
Propylthiouracil—Neuropathy peripheral—Melphalan—ovarian cancer	0.00159	0.00631	CcSEcCtD
Propylthiouracil—Jaundice—Melphalan—ovarian cancer	0.00158	0.00627	CcSEcCtD
Propylthiouracil—DBH—bone marrow—ovarian cancer	0.00153	0.111	CbGeAlD
Propylthiouracil—MPO—Folate Metabolism—SOD1—ovarian cancer	0.00152	0.00583	CbGpPWpGaD
Propylthiouracil—Haemoglobin—Topotecan—ovarian cancer	0.00149	0.00593	CcSEcCtD
Propylthiouracil—Haemorrhage—Topotecan—ovarian cancer	0.00148	0.0059	CcSEcCtD
Propylthiouracil—Alopecia—Chlorambucil—ovarian cancer	0.00147	0.00586	CcSEcCtD
Propylthiouracil—Haemoglobin—Melphalan—ovarian cancer	0.00146	0.00581	CcSEcCtD
Propylthiouracil—Hepatitis—Melphalan—ovarian cancer	0.00145	0.00578	CcSEcCtD
Propylthiouracil—Haemorrhage—Melphalan—ovarian cancer	0.00145	0.00578	CcSEcCtD
Propylthiouracil—Neuropathy peripheral—Vinorelbine—ovarian cancer	0.00139	0.00551	CcSEcCtD
Propylthiouracil—MPO—Folate Metabolism—SOD2—ovarian cancer	0.00137	0.00525	CbGpPWpGaD
Propylthiouracil—DBH—Amino acid and derivative metabolism—SLC5A5—ovarian cancer	0.00135	0.00519	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—NME2—ovarian cancer	0.00134	0.00515	CbGpPWpGaD
Propylthiouracil—Renal failure acute—Paclitaxel—ovarian cancer	0.00134	0.00532	CcSEcCtD
Propylthiouracil—Agranulocytosis—Vinorelbine—ovarian cancer	0.00132	0.00525	CcSEcCtD
Propylthiouracil—Alopecia—Topotecan—ovarian cancer	0.00131	0.00521	CcSEcCtD
Propylthiouracil—Dermatitis exfoliative—Paclitaxel—ovarian cancer	0.00131	0.0052	CcSEcCtD
Propylthiouracil—Neuritis—Epirubicin—ovarian cancer	0.0013	0.00518	CcSEcCtD
Propylthiouracil—Leukopenia—Chlorambucil—ovarian cancer	0.0013	0.00517	CcSEcCtD
Propylthiouracil—Alopecia—Melphalan—ovarian cancer	0.00128	0.00511	CcSEcCtD
Propylthiouracil—TPO—Amino acid and derivative metabolism—SLC5A5—ovarian cancer	0.00127	0.00488	CbGpPWpGaD
Propylthiouracil—Skin ulcer—Epirubicin—ovarian cancer	0.00125	0.00497	CcSEcCtD
Propylthiouracil—TPO—Differentiation Pathway—VEGFA—ovarian cancer	0.00124	0.00478	CbGpPWpGaD
Propylthiouracil—MPO—Selenium Micronutrient Network—SOD1—ovarian cancer	0.00121	0.00463	CbGpPWpGaD
Propylthiouracil—Neuritis—Doxorubicin—ovarian cancer	0.0012	0.00479	CcSEcCtD
Propylthiouracil—Ageusia—Epirubicin—ovarian cancer	0.0012	0.00477	CcSEcCtD
Propylthiouracil—MPO—epithelium—ovarian cancer	0.00117	0.0849	CbGeAlD
Propylthiouracil—Hepatic failure—Docetaxel—ovarian cancer	0.00116	0.00463	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Chlorambucil—ovarian cancer	0.00116	0.00461	CcSEcCtD
Propylthiouracil—Leukopenia—Topotecan—ovarian cancer	0.00116	0.0046	CcSEcCtD
Propylthiouracil—Skin ulcer—Doxorubicin—ovarian cancer	0.00116	0.00459	CcSEcCtD
Propylthiouracil—Liver injury—Epirubicin—ovarian cancer	0.00116	0.00459	CcSEcCtD
Propylthiouracil—Leukopenia—Melphalan—ovarian cancer	0.00113	0.0045	CcSEcCtD
Propylthiouracil—MPO—IL23-mediated signaling events—IL2—ovarian cancer	0.00113	0.00434	CbGpPWpGaD
Propylthiouracil—Alopecia—Vinorelbine—ovarian cancer	0.00112	0.00446	CcSEcCtD
Propylthiouracil—Ageusia—Doxorubicin—ovarian cancer	0.00111	0.00442	CcSEcCtD
Propylthiouracil—Myalgia—Topotecan—ovarian cancer	0.0011	0.00437	CcSEcCtD
Propylthiouracil—Arthralgia—Topotecan—ovarian cancer	0.0011	0.00437	CcSEcCtD
Propylthiouracil—MPO—Selenium Micronutrient Network—SOD2—ovarian cancer	0.00109	0.00417	CbGpPWpGaD
Propylthiouracil—Myalgia—Melphalan—ovarian cancer	0.00108	0.00428	CcSEcCtD
Propylthiouracil—Liver injury—Doxorubicin—ovarian cancer	0.00107	0.00425	CcSEcCtD
Propylthiouracil—Dyspepsia—Chlorambucil—ovarian cancer	0.00104	0.00415	CcSEcCtD
Propylthiouracil—Oedema—Melphalan—ovarian cancer	0.00103	0.00411	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Topotecan—ovarian cancer	0.00103	0.00411	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Melphalan—ovarian cancer	0.00101	0.00402	CcSEcCtD
Propylthiouracil—TPO—Hematopoietic Stem Cell Differentiation—IL6—ovarian cancer	0.000995	0.00383	CbGpPWpGaD
Propylthiouracil—Vertigo—Vinorelbine—ovarian cancer	0.000993	0.00395	CcSEcCtD
Propylthiouracil—Leukopenia—Vinorelbine—ovarian cancer	0.000989	0.00393	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Topotecan—ovarian cancer	0.00096	0.00382	CcSEcCtD
Propylthiouracil—MPO—IL23-mediated signaling events—STAT3—ovarian cancer	0.000951	0.00365	CbGpPWpGaD
Propylthiouracil—DBH—lymph node—ovarian cancer	0.00095	0.069	CbGeAlD
Propylthiouracil—Paraesthesia—Topotecan—ovarian cancer	0.000947	0.00376	CcSEcCtD
Propylthiouracil—Urticaria—Chlorambucil—ovarian cancer	0.000941	0.00374	CcSEcCtD
Propylthiouracil—Myalgia—Vinorelbine—ovarian cancer	0.000941	0.00374	CcSEcCtD
Propylthiouracil—Arthralgia—Vinorelbine—ovarian cancer	0.000941	0.00374	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Melphalan—ovarian cancer	0.00094	0.00374	CcSEcCtD
Propylthiouracil—Body temperature increased—Chlorambucil—ovarian cancer	0.000936	0.00372	CcSEcCtD
Propylthiouracil—Neuropathy peripheral—Paclitaxel—ovarian cancer	0.000932	0.00371	CcSEcCtD
Propylthiouracil—Dyspepsia—Topotecan—ovarian cancer	0.000928	0.00369	CcSEcCtD
Propylthiouracil—Paraesthesia—Melphalan—ovarian cancer	0.000927	0.00369	CcSEcCtD
Propylthiouracil—DIO1—Selenium Micronutrient Network—IL6—ovarian cancer	0.000922	0.00354	CbGpPWpGaD
Propylthiouracil—Aplastic anaemia—Epirubicin—ovarian cancer	0.000913	0.00363	CcSEcCtD
Propylthiouracil—Dyspepsia—Melphalan—ovarian cancer	0.000909	0.00361	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Vinorelbine—ovarian cancer	0.000883	0.00351	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—CYTB—ovarian cancer	0.000863	0.00332	CbGpPWpGaD
Propylthiouracil—TPO—Differentiation Pathway—IL6—ovarian cancer	0.00086	0.00331	CbGpPWpGaD
Propylthiouracil—Haemoglobin—Paclitaxel—ovarian cancer	0.000858	0.00341	CcSEcCtD
Propylthiouracil—Haemorrhage—Paclitaxel—ovarian cancer	0.000854	0.0034	CcSEcCtD
Propylthiouracil—Aplastic anaemia—Doxorubicin—ovarian cancer	0.000844	0.00336	CcSEcCtD
Propylthiouracil—Pruritus—Chlorambucil—ovarian cancer	0.000838	0.00333	CcSEcCtD
Propylthiouracil—Urticaria—Topotecan—ovarian cancer	0.000837	0.00333	CcSEcCtD
Propylthiouracil—Body temperature increased—Topotecan—ovarian cancer	0.000833	0.00331	CcSEcCtD
Propylthiouracil—Lymphadenopathy—Epirubicin—ovarian cancer	0.000827	0.00329	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.000822	0.00327	CcSEcCtD
Propylthiouracil—MPO—bone marrow—ovarian cancer	0.00082	0.0595	CbGeAlD
Propylthiouracil—Urticaria—Melphalan—ovarian cancer	0.00082	0.00326	CcSEcCtD
Propylthiouracil—DBH—Metabolism—NME2—ovarian cancer	0.000818	0.00315	CbGpPWpGaD
Propylthiouracil—Paraesthesia—Vinorelbine—ovarian cancer	0.00081	0.00322	CcSEcCtD
Propylthiouracil—Neuropathy peripheral—Docetaxel—ovarian cancer	0.00079	0.00314	CcSEcCtD
Propylthiouracil—Jaundice—Docetaxel—ovarian cancer	0.000786	0.00313	CcSEcCtD
Propylthiouracil—Hepatic failure—Epirubicin—ovarian cancer	0.000785	0.00312	CcSEcCtD
Propylthiouracil—TPO—Metabolism—NME2—ovarian cancer	0.000769	0.00296	CbGpPWpGaD
Propylthiouracil—Lymphadenopathy—Doxorubicin—ovarian cancer	0.000765	0.00304	CcSEcCtD
Propylthiouracil—Renal failure acute—Epirubicin—ovarian cancer	0.000764	0.00304	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—PPP1CC—ovarian cancer	0.000755	0.0029	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—BRIP1—ovarian cancer	0.000755	0.0029	CbGpPWpGaD
Propylthiouracil—Alopecia—Paclitaxel—ovarian cancer	0.000754	0.003	CcSEcCtD
Propylthiouracil—Vomiting—Chlorambucil—ovarian cancer	0.000753	0.00299	CcSEcCtD
Propylthiouracil—Agranulocytosis—Docetaxel—ovarian cancer	0.000752	0.00299	CcSEcCtD
Propylthiouracil—MPO—IL23-mediated signaling events—PIK3CA—ovarian cancer	0.00075	0.00288	CbGpPWpGaD
Propylthiouracil—Dermatitis exfoliative—Epirubicin—ovarian cancer	0.000748	0.00297	CcSEcCtD
Propylthiouracil—Pruritus—Topotecan—ovarian cancer	0.000746	0.00297	CcSEcCtD
Propylthiouracil—Pruritus—Melphalan—ovarian cancer	0.00073	0.0029	CcSEcCtD
Propylthiouracil—Dysgeusia—Paclitaxel—ovarian cancer	0.000728	0.00289	CcSEcCtD
Propylthiouracil—Haemoglobin—Docetaxel—ovarian cancer	0.000727	0.00289	CcSEcCtD
Propylthiouracil—Hepatic failure—Doxorubicin—ovarian cancer	0.000726	0.00289	CcSEcCtD
Propylthiouracil—Hepatitis—Docetaxel—ovarian cancer	0.000724	0.00288	CcSEcCtD
Propylthiouracil—Haemorrhage—Docetaxel—ovarian cancer	0.000724	0.00288	CcSEcCtD
Propylthiouracil—Urticaria—Vinorelbine—ovarian cancer	0.000716	0.00285	CcSEcCtD
Propylthiouracil—Body temperature increased—Vinorelbine—ovarian cancer	0.000713	0.00284	CcSEcCtD
Propylthiouracil—MPO—Folate Metabolism—IL2—ovarian cancer	0.000711	0.00273	CbGpPWpGaD
Propylthiouracil—Renal failure acute—Doxorubicin—ovarian cancer	0.000707	0.00281	CcSEcCtD
Propylthiouracil—Nausea—Chlorambucil—ovarian cancer	0.000703	0.0028	CcSEcCtD
Propylthiouracil—MPO—testis—ovarian cancer	0.000701	0.0509	CbGeAlD
Propylthiouracil—Dermatitis exfoliative—Doxorubicin—ovarian cancer	0.000692	0.00275	CcSEcCtD
Propylthiouracil—Vomiting—Topotecan—ovarian cancer	0.00067	0.00267	CcSEcCtD
Propylthiouracil—Vertigo—Paclitaxel—ovarian cancer	0.000668	0.00266	CcSEcCtD
Propylthiouracil—Leukopenia—Paclitaxel—ovarian cancer	0.000665	0.00265	CcSEcCtD
Propylthiouracil—Rash—Topotecan—ovarian cancer	0.000665	0.00264	CcSEcCtD
Propylthiouracil—Dermatitis—Topotecan—ovarian cancer	0.000664	0.00264	CcSEcCtD
Propylthiouracil—MPO—IL23-mediated signaling events—IL6—ovarian cancer	0.000664	0.00255	CbGpPWpGaD
Propylthiouracil—Headache—Topotecan—ovarian cancer	0.00066	0.00263	CcSEcCtD
Propylthiouracil—Vomiting—Melphalan—ovarian cancer	0.000656	0.00261	CcSEcCtD
Propylthiouracil—Rash—Melphalan—ovarian cancer	0.000651	0.00259	CcSEcCtD
Propylthiouracil—Dermatitis—Melphalan—ovarian cancer	0.00065	0.00259	CcSEcCtD
Propylthiouracil—Alopecia—Docetaxel—ovarian cancer	0.000639	0.00254	CcSEcCtD
Propylthiouracil—Pruritus—Vinorelbine—ovarian cancer	0.000638	0.00254	CcSEcCtD
Propylthiouracil—Arthralgia—Paclitaxel—ovarian cancer	0.000633	0.00252	CcSEcCtD
Propylthiouracil—Myalgia—Paclitaxel—ovarian cancer	0.000633	0.00252	CcSEcCtD
Propylthiouracil—Nausea—Topotecan—ovarian cancer	0.000626	0.00249	CcSEcCtD
Propylthiouracil—Dysgeusia—Docetaxel—ovarian cancer	0.000617	0.00245	CcSEcCtD
Propylthiouracil—Nausea—Melphalan—ovarian cancer	0.000613	0.00244	CcSEcCtD
Propylthiouracil—Oedema—Paclitaxel—ovarian cancer	0.000607	0.00241	CcSEcCtD
Propylthiouracil—MPO—C-MYB transcription factor network—CDKN1B—ovarian cancer	0.000599	0.0023	CbGpPWpGaD
Propylthiouracil—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000594	0.00236	CcSEcCtD
Propylthiouracil—Vomiting—Vinorelbine—ovarian cancer	0.000573	0.00228	CcSEcCtD
Propylthiouracil—MPO—C-MYB transcription factor network—CCND1—ovarian cancer	0.000571	0.0022	CbGpPWpGaD
Propylthiouracil—Rash—Vinorelbine—ovarian cancer	0.000569	0.00226	CcSEcCtD
Propylthiouracil—Dermatitis—Vinorelbine—ovarian cancer	0.000568	0.00226	CcSEcCtD
Propylthiouracil—Headache—Vinorelbine—ovarian cancer	0.000565	0.00225	CcSEcCtD
Propylthiouracil—Leukopenia—Docetaxel—ovarian cancer	0.000564	0.00224	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000553	0.0022	CcSEcCtD
Propylthiouracil—Paraesthesia—Paclitaxel—ovarian cancer	0.000545	0.00217	CcSEcCtD
Propylthiouracil—Drowsiness—Epirubicin—ovarian cancer	0.000544	0.00216	CcSEcCtD
Propylthiouracil—Somnolence—Paclitaxel—ovarian cancer	0.000539	0.00214	CcSEcCtD
Propylthiouracil—Arthralgia—Docetaxel—ovarian cancer	0.000536	0.00213	CcSEcCtD
Propylthiouracil—Myalgia—Docetaxel—ovarian cancer	0.000536	0.00213	CcSEcCtD
Propylthiouracil—Nausea—Vinorelbine—ovarian cancer	0.000536	0.00213	CcSEcCtD
Propylthiouracil—Dyspepsia—Paclitaxel—ovarian cancer	0.000534	0.00212	CcSEcCtD
Propylthiouracil—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000533	0.00212	CcSEcCtD
Propylthiouracil—Jaundice—Epirubicin—ovarian cancer	0.00053	0.00211	CcSEcCtD
Propylthiouracil—DBH—Metabolism—CYTB—ovarian cancer	0.000527	0.00203	CbGpPWpGaD
Propylthiouracil—Oedema—Docetaxel—ovarian cancer	0.000514	0.00204	CcSEcCtD
Propylthiouracil—MPO—Vitamin B12 Metabolism—IL6—ovarian cancer	0.000514	0.00197	CbGpPWpGaD
Propylthiouracil—MPO—lymph node—ovarian cancer	0.000508	0.0369	CbGeAlD
Propylthiouracil—Agranulocytosis—Epirubicin—ovarian cancer	0.000507	0.00202	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—YAP1—ovarian cancer	0.000506	0.00195	CbGpPWpGaD
Propylthiouracil—Thrombocytopenia—Docetaxel—ovarian cancer	0.000503	0.002	CcSEcCtD
Propylthiouracil—Drowsiness—Doxorubicin—ovarian cancer	0.000503	0.002	CcSEcCtD
Propylthiouracil—TPO—Metabolism—CYTB—ovarian cancer	0.000496	0.00191	CbGpPWpGaD
Propylthiouracil—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000493	0.00196	CcSEcCtD
Propylthiouracil—MPO—C-MYB transcription factor network—NRAS—ovarian cancer	0.000492	0.00189	CbGpPWpGaD
Propylthiouracil—Haemoglobin—Epirubicin—ovarian cancer	0.000491	0.00195	CcSEcCtD
Propylthiouracil—Jaundice—Doxorubicin—ovarian cancer	0.00049	0.00195	CcSEcCtD
Propylthiouracil—Haemorrhage—Epirubicin—ovarian cancer	0.000488	0.00194	CcSEcCtD
Propylthiouracil—Hepatitis—Epirubicin—ovarian cancer	0.000488	0.00194	CcSEcCtD
Propylthiouracil—Urticaria—Paclitaxel—ovarian cancer	0.000482	0.00192	CcSEcCtD
Propylthiouracil—Body temperature increased—Paclitaxel—ovarian cancer	0.000479	0.00191	CcSEcCtD
Propylthiouracil—Agranulocytosis—Doxorubicin—ovarian cancer	0.000469	0.00187	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000468	0.00186	CcSEcCtD
Propylthiouracil—Paraesthesia—Docetaxel—ovarian cancer	0.000462	0.00184	CcSEcCtD
Propylthiouracil—DBH—Metabolism—PPP1CC—ovarian cancer	0.000461	0.00177	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—BRIP1—ovarian cancer	0.000461	0.00177	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—MYC—ovarian cancer	0.000458	0.00176	CbGpPWpGaD
Propylthiouracil—Somnolence—Docetaxel—ovarian cancer	0.000457	0.00182	CcSEcCtD
Propylthiouracil—MPO—Folate Metabolism—TP53—ovarian cancer	0.000457	0.00175	CbGpPWpGaD
Propylthiouracil—Haemoglobin—Doxorubicin—ovarian cancer	0.000454	0.00181	CcSEcCtD
Propylthiouracil—Dyspepsia—Docetaxel—ovarian cancer	0.000453	0.0018	CcSEcCtD
Propylthiouracil—Hepatitis—Doxorubicin—ovarian cancer	0.000452	0.0018	CcSEcCtD
Propylthiouracil—Haemorrhage—Doxorubicin—ovarian cancer	0.000452	0.0018	CcSEcCtD
Propylthiouracil—TPO—Metabolism—PPP1CC—ovarian cancer	0.000433	0.00167	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—BRIP1—ovarian cancer	0.000433	0.00167	CbGpPWpGaD
Propylthiouracil—Alopecia—Epirubicin—ovarian cancer	0.000431	0.00172	CcSEcCtD
Propylthiouracil—Pruritus—Paclitaxel—ovarian cancer	0.000429	0.00171	CcSEcCtD
Propylthiouracil—MPO—C-MYB transcription factor network—KRAS—ovarian cancer	0.000424	0.00163	CbGpPWpGaD
Propylthiouracil—MPO—Folate Metabolism—IL6—ovarian cancer	0.000418	0.00161	CbGpPWpGaD
Propylthiouracil—Dysgeusia—Epirubicin—ovarian cancer	0.000416	0.00165	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—FASN—ovarian cancer	0.000413	0.00159	CbGpPWpGaD
Propylthiouracil—Body temperature increased—Docetaxel—ovarian cancer	0.000406	0.00162	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—SLC5A5—ovarian cancer	0.000406	0.00156	CbGpPWpGaD
Propylthiouracil—Alopecia—Doxorubicin—ovarian cancer	0.000399	0.00159	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—SLC2A1—ovarian cancer	0.000392	0.00151	CbGpPWpGaD
Propylthiouracil—Vomiting—Paclitaxel—ovarian cancer	0.000386	0.00153	CcSEcCtD
Propylthiouracil—Dysgeusia—Doxorubicin—ovarian cancer	0.000385	0.00153	CcSEcCtD
Propylthiouracil—Rash—Paclitaxel—ovarian cancer	0.000382	0.00152	CcSEcCtD
Propylthiouracil—Dermatitis—Paclitaxel—ovarian cancer	0.000382	0.00152	CcSEcCtD
Propylthiouracil—Vertigo—Epirubicin—ovarian cancer	0.000382	0.00152	CcSEcCtD
Propylthiouracil—Leukopenia—Epirubicin—ovarian cancer	0.00038	0.00151	CcSEcCtD
Propylthiouracil—Headache—Paclitaxel—ovarian cancer	0.00038	0.00151	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—CYP1B1—ovarian cancer	0.000376	0.00144	CbGpPWpGaD
Propylthiouracil—Pruritus—Docetaxel—ovarian cancer	0.000364	0.00145	CcSEcCtD
Propylthiouracil—Myalgia—Epirubicin—ovarian cancer	0.000362	0.00144	CcSEcCtD
Propylthiouracil—Arthralgia—Epirubicin—ovarian cancer	0.000362	0.00144	CcSEcCtD
Propylthiouracil—Nausea—Paclitaxel—ovarian cancer	0.00036	0.00143	CcSEcCtD
Propylthiouracil—MPO—C-MYB transcription factor network—HRAS—ovarian cancer	0.00036	0.00138	CbGpPWpGaD
Propylthiouracil—Vertigo—Doxorubicin—ovarian cancer	0.000353	0.0014	CcSEcCtD
Propylthiouracil—Leukopenia—Doxorubicin—ovarian cancer	0.000352	0.0014	CcSEcCtD
Propylthiouracil—Oedema—Epirubicin—ovarian cancer	0.000347	0.00138	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Epirubicin—ovarian cancer	0.00034	0.00135	CcSEcCtD
Propylthiouracil—Arthralgia—Doxorubicin—ovarian cancer	0.000335	0.00133	CcSEcCtD
Propylthiouracil—Myalgia—Doxorubicin—ovarian cancer	0.000335	0.00133	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—PPP2R1A—ovarian cancer	0.000333	0.00128	CbGpPWpGaD
Propylthiouracil—MPO—Selenium Micronutrient Network—IL6—ovarian cancer	0.000332	0.00128	CbGpPWpGaD
Propylthiouracil—Vomiting—Docetaxel—ovarian cancer	0.000327	0.0013	CcSEcCtD
Propylthiouracil—Rash—Docetaxel—ovarian cancer	0.000324	0.00129	CcSEcCtD
Propylthiouracil—Dermatitis—Docetaxel—ovarian cancer	0.000324	0.00129	CcSEcCtD
Propylthiouracil—Headache—Docetaxel—ovarian cancer	0.000322	0.00128	CcSEcCtD
Propylthiouracil—Oedema—Doxorubicin—ovarian cancer	0.000321	0.00128	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000316	0.00126	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000314	0.00125	CcSEcCtD
Propylthiouracil—Paraesthesia—Epirubicin—ovarian cancer	0.000311	0.00124	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—ABCB1—ovarian cancer	0.000309	0.00119	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—YAP1—ovarian cancer	0.000309	0.00119	CbGpPWpGaD
Propylthiouracil—Somnolence—Epirubicin—ovarian cancer	0.000308	0.00123	CcSEcCtD
Propylthiouracil—Nausea—Docetaxel—ovarian cancer	0.000305	0.00121	CcSEcCtD
Propylthiouracil—Dyspepsia—Epirubicin—ovarian cancer	0.000305	0.00121	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—TYMS—ovarian cancer	0.000304	0.00117	CbGpPWpGaD
Propylthiouracil—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000292	0.00116	CcSEcCtD
Propylthiouracil—TPO—Metabolism—YAP1—ovarian cancer	0.000291	0.00112	CbGpPWpGaD
Propylthiouracil—Paraesthesia—Doxorubicin—ovarian cancer	0.000288	0.00115	CcSEcCtD
Propylthiouracil—Somnolence—Doxorubicin—ovarian cancer	0.000285	0.00113	CcSEcCtD
Propylthiouracil—Dyspepsia—Doxorubicin—ovarian cancer	0.000282	0.00112	CcSEcCtD
Propylthiouracil—Urticaria—Epirubicin—ovarian cancer	0.000275	0.0011	CcSEcCtD
Propylthiouracil—Body temperature increased—Epirubicin—ovarian cancer	0.000274	0.00109	CcSEcCtD
Propylthiouracil—Urticaria—Doxorubicin—ovarian cancer	0.000255	0.00101	CcSEcCtD
Propylthiouracil—Body temperature increased—Doxorubicin—ovarian cancer	0.000254	0.00101	CcSEcCtD
Propylthiouracil—DBH—Metabolism—FASN—ovarian cancer	0.000252	0.000969	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—SLC5A5—ovarian cancer	0.000248	0.000953	CbGpPWpGaD
Propylthiouracil—Pruritus—Epirubicin—ovarian cancer	0.000245	0.000976	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—CAV1—ovarian cancer	0.000245	0.000941	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—SLC2A1—ovarian cancer	0.000239	0.00092	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—FASN—ovarian cancer	0.000237	0.000911	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—SLC5A5—ovarian cancer	0.000233	0.000896	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—CYP1B1—ovarian cancer	0.00023	0.000882	CbGpPWpGaD
Propylthiouracil—Pruritus—Doxorubicin—ovarian cancer	0.000227	0.000903	CcSEcCtD
Propylthiouracil—TPO—Metabolism—SLC2A1—ovarian cancer	0.000225	0.000865	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PIK3CG—ovarian cancer	0.000223	0.000857	CbGpPWpGaD
Propylthiouracil—Vomiting—Epirubicin—ovarian cancer	0.00022	0.000877	CcSEcCtD
Propylthiouracil—Rash—Epirubicin—ovarian cancer	0.000219	0.00087	CcSEcCtD
Propylthiouracil—Dermatitis—Epirubicin—ovarian cancer	0.000218	0.000869	CcSEcCtD
Propylthiouracil—Headache—Epirubicin—ovarian cancer	0.000217	0.000864	CcSEcCtD
Propylthiouracil—TPO—Metabolism—CYP1B1—ovarian cancer	0.000216	0.000829	CbGpPWpGaD
Propylthiouracil—Nausea—Epirubicin—ovarian cancer	0.000206	0.000819	CcSEcCtD
Propylthiouracil—Vomiting—Doxorubicin—ovarian cancer	0.000204	0.000811	CcSEcCtD
Propylthiouracil—DBH—Metabolism—PPP2R1A—ovarian cancer	0.000204	0.000782	CbGpPWpGaD
Propylthiouracil—Rash—Doxorubicin—ovarian cancer	0.000202	0.000805	CcSEcCtD
Propylthiouracil—Dermatitis—Doxorubicin—ovarian cancer	0.000202	0.000804	CcSEcCtD
Propylthiouracil—Headache—Doxorubicin—ovarian cancer	0.000201	0.000799	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—PIK3CD—ovarian cancer	0.000196	0.000754	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PPP2R1A—ovarian cancer	0.000191	0.000736	CbGpPWpGaD
Propylthiouracil—Nausea—Doxorubicin—ovarian cancer	0.000191	0.000758	CcSEcCtD
Propylthiouracil—DBH—Metabolism—ABCB1—ovarian cancer	0.000189	0.000726	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—TYMS—ovarian cancer	0.000186	0.000714	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—ABCB1—ovarian cancer	0.000178	0.000683	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—TYMS—ovarian cancer	0.000175	0.000671	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PIK3CB—ovarian cancer	0.000171	0.000657	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—CAV1—ovarian cancer	0.00015	0.000575	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PTEN—ovarian cancer	0.000148	0.000568	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CAV1—ovarian cancer	0.000141	0.000541	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PIK3CG—ovarian cancer	0.000136	0.000524	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PIK3CG—ovarian cancer	0.000128	0.000492	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PIK3CD—ovarian cancer	0.00012	0.00046	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PIK3CD—ovarian cancer	0.000113	0.000433	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PIK3CB—ovarian cancer	0.000104	0.000401	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PIK3CA—ovarian cancer	0.000104	0.0004	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PIK3CB—ovarian cancer	9.82e-05	0.000377	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PTEN—ovarian cancer	9.02e-05	0.000347	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—AKT1—ovarian cancer	8.51e-05	0.000327	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PTEN—ovarian cancer	8.48e-05	0.000326	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PIK3CA—ovarian cancer	6.36e-05	0.000245	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PIK3CA—ovarian cancer	5.98e-05	0.00023	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—AKT1—ovarian cancer	5.2e-05	0.0002	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—AKT1—ovarian cancer	4.89e-05	0.000188	CbGpPWpGaD
